Research grant will support the development of novel dosage forms and clinical studies
NANAIMO, BC, Nov. 30, 2017 /CNW/ -Â Tilray, a global leader in medical cannabis research and production, today announced that the company has received research grant from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) to support product development and other research projects. Widely considered one of the premier programs of its kind, the NRC-IRAP provides assistance to Canadian businesses to undertake technology innovation through a comprehensive suite of innovation services and funding.
“Tilray is committed to advancing our scientific understanding of medical cannabis to benefit patients with a diverse array of conditions,” said Dr. Joshua Eades, PhD, Tilray’s Chief Science Officer. “We are honoured to receive this funding from the NRC-IRAP to support our research.